Expert panel disagreed on evidence, but overwhelmingly voted for labeling potentially fatal risks
Read the rest here:
FDA wants blood clot risks added to Yaz labels
If you enjoyed this post, make sure you subscribe to my RSS feed!
Expert panel disagreed on evidence, but overwhelmingly voted for labeling potentially fatal risks
Read the rest here:
FDA wants blood clot risks added to Yaz labels
Tagged with: disagreed-on-evidence fatal-risks news panel-disagreed